. The agency formed partnerships w ith key fed eral, public, private, and voluntary organizations and launched a con certed effort to stimulate adult immunization activities in the public and private sectors. D uring the past ten years, CDC has taken the fol lowing steps:
1. Helped to establish and worked to increase public and provider awareness, in partnership with the National Coalition for Adult Immunization (NCAI) (which comprises more than 70 major organizations) 2. Helped to develop and published N C A Is Standards for Adult Immunization Practice (Centers for Disease Control 1990) 3. Worked for the adoption of National Adult Immunization Aware ness Week (celebrated annually during the last week of October) by Presidential proclamation 4. Convened symposia focused on improving adult immunization practices among providers 5. Developed educational materials and training activities for health care providers, health profession students, and consumers 6. Conducted studies to assess patient and provider factors influ encing vaccination, and published the findings (Williams 1992) 7. Executed major demonstration projects to assess promising in terventions, to develop models for community coalition build ing, and to establish effective vaccine delivery mechanisms for adults (Campbell et al. 1993 ; Centers for Disease Control and Prevention 1993) 8. Worked directly with the Health Care Financing Administra tion (HCFA), the National Institute on Aging (NIA), and other federal agencies on provider-and patient-targeted activities to enhance adult immunization 9. Worked with its public and private partners, vaccine companies, and the managed care industry to improve vaccination services for adults 10. Improved disease surveillance activities 11. Conducted research on programmatic and technical issues affect ing adult immunization 12. Refined mechanisms to evaluate the impact of immunization activities on levels of protection and morbidity
Healthy People Year 2 0 0 0 Goals
The objectives set in the Healthy People Year 2000 report (U.S. Public Health Service 1991) should serve as the yardstick for measuring na tional progress in improving the health of adults and children in the United States. Twenty-two expert working groups, a consortium of al most 300 national organizations, every state health department, the In stitute of Medicine, and many others contributed to this national effort to set disease prevention goals. One objective put forth in Healthy People 2000 is to assure that 60 percent of adults 65 years of age and older receive the influenza and pneumococcal vaccination by the year 2000. As CDC's activities, described above, have gained mom entum , vaccination levels have im proved. For older persons, influenza and pneumococcal vaccination rates have increased, although not to optimal levels. Approximately 40,000 to 70,000 adults die from vaccine-preventable illnesses every year. Data gathered in 1993 from the National Health Interview Sur vey (NHIS), the recognized data source, show influenza immuniza tion coverage at 52 percent, close to the Healthy People goal of 60 percent (Centers for Disease Control and Prevention 1995b). Further more, according to preliminary data from an HCFA survey, the 1994 level reached 61 percent, which means that this Healthy People goal may have been met six years before the target date. The General Accounting Office has recently acknowledged that significant progress has been made in the use of the influenza vaccine. Pneumococcal im munization rates doubled from 14 percent in 1989 to 28 percent in 1993 (Centers for Disease Control and Prevention 1995b). Although the na tion is on track to meet the Healthy People 2000 goal of 60 percent, we are still a good way from achieving it.
Although these im munization levels are the highest ever recorded among older U.S. adults, further progress is required, especially among certain populations with substantially lower coverage, like African Ameri cans and adults w ith certain high-risk or chronic conditions. Also, con siderable energy must be directed toward continuing effective vaccination strategies for pneumococcal disease. These remaining challenges should not prevent us from acknowledging historic advances and, more impor tant, from applying what we have learned to achieve even more satis factory levels of protection of adults against vaccine-preventable diseases and deaths.
Partners in A dult Immunization Activities
Extensive collaboration among public, private, and voluntary organiza tions has resulted in greatly increased immunization coverage of adults. For example, HCFA clearly has a central role to play in improving vaccination levels of older persons through its Medicare program. Medi care has covered pneumococcal vaccination since 1981. HCFA worked w ith CDC and the National Vaccine Program Office on the five-year, m ultim illion-dollar Medicare Influenza Demonstration Project, which showed the life-saving and cost-saving benefits that could accrue from more widespread use of the influenza vaccine. This project proved that effective intervention strategies could achieve target vaccination levels. W ith evidence that an influenza immunization benefit may provide a cost savings to Medicare, HCFA established a reimbursement policy for flu immunization in 1993. Additionally, HCFA changed program di rection and priorities. In Fiscal Year (FY) 1995, HCFA expended just over $100 million to administer and promote influenza and pneumo coccal vaccination for Medicare beneficiaries.
HCFA has taken aggressive action to support strategies that will reduce disease. Its Consumer Information Strategy uses Medicare claims data to efficiently target areas with low immunization rates, to help state health departments expand awareness, and to utilize partnership activities and national media networks to reach the largest possible number of beneficiaries in a cost-effective way (Vladeck 1994) . HCFA prepared and distributed 10,500 information kits in 1994 to large con sumer and provider organizations that, in turn, used the materials to increase immunization coverage. These organizations included the Ameri can Medical Association, the American Association of Retired Persons, the Group Health Association of America, and the American Hospital Association. HCFA has also engaged contractors in every state to work on an adult immunization promotional campaign currently being waged by hundreds of local organizations around the country.
New collaborative efforts have expanded upon the successful collabo ration between HCFA and CDC in the Influenza Demonstration Project. HCFA has developed a five-year plan called "Flu 2000," which contains strategies for improving influenza and pneumococcal vaccination cov erage. Both CDC and NCAI contributed their knowledge and expertise to the development of this plan. HCFA is also initiating a minority health program called Horizons, which will focus on encouraging use of preventive services by minority and underserved populations. The first Horizons project is a collaborative effort between Peer Review Organizations and historically black colleges and universities in eight southeastern states to develop intervention strategies for increasing flu immunization rates in African-American Medicare beneficiaries. The D epartm ent of H ealth and H um an Services has also examined the issues surrounding adult im munization in a comprehensive and sys tematic fashion and has developed its own strategy. After a two-and-ahalf-year deliberative process supported by CDC, the National Vaccine Advisory Com m ittee (NVAC) Report on A dult Im m unization was adopted in January 1994 and sent to Assistant Secretary of Health Philip R. Lee (N ational Vaccine Advisory Committee 1994; Fedson 1994) . The NVAC is a government advisory group composed of a wide spectrum of representatives from the public and private sectors. The NVAC report establishes five major goals for improving adult im m u nization in the United States. It contains 18 recommendations for achiev ing these goals, devises 72 strategies for implementation, and focuses on policy issues that underlie all aspects of adult immunization, including research and development, safety and efficacy, availability, cost, distri bution, and use of vaccines by adults (National Vaccine Advisory Com mittee 1994; Fedson 1994) . This report clearly states that improving adult immunization will require not only a substantial CDC role but also close working relations among other federal agencies, health care professionals, vaccine companies, and the payers for health care services. The NVAC report reflects the government's aggressive leadership in studying and addressing adult immunization issues.
National Priorities in A dult Immunization
Whereas HCFA, through the Medicare program, has made adult im munization one of its highest priorities, the Congress has indicated unequivocally that children should be CDCs immunization priority. For example, in the FY 1990-95 House and Senate Appropriations Committee reports related to CDC, childhood immunization was di rectly addressed frequently and repeatedly, whereas adult immunization was m entioned only once in these six years. In fact, each House report channels all of the immunization funding to CDC under the heading "Childhood Immunization Program." In addition, the most recent House authorization hearing for CDC immunization activities was entitled "Childhood Immunization Program Reauthorization." Finally, CDC has worked closely w ith congressional staff members over the years. W ith out question, they have clearly indicated that CDC was to pursue child hood immunization activities first and foremost. Although CDC has always acknowledged its authority to conduct adult immunization ac tivities, and although it does carry out substantive efforts with limited resources, as noted above, it would be inappropriate to ignore the clearly expressed wishes of the Congress.
Childhood immunization is a high priority of the current adminis tration. Shortly after taking office, President Clinton launched the na tional Childhood Im m unization Initiative, a five-part program and strategy to raise immunization levels of preschool children to at least 90 percent for most childhood vaccine-preventable diseases by 1996, and to decrease the incidence of these diseases to zero, or near-zero, levels over the same time period (Centers for Disease Control and Prevention 1994). CDC has worked aggressively with partners at all levels to make this national initiative a reality and a success.
The Negative Impact o f Reordering Immunization Priorities
Jason Lee suggests shifting CDC resources from childhood to adult immunization. CDC has estimated that in order to increase adult im munization rates in a meaningful way, an expenditure of from $34 to $80 million would be required, depending on the comprehensiveness of the program design. Removal of these funds from the National Immu nization Program s childhood immunization activities would result in the termination of major preventive activities and significant decreases in coverage, and could lead to higher rates of childhood disease. His torically, when federal funding for immunization has decreased, disease incidence has gone up. For example, when measles funding decreased from 1968 to 1969, cases tripled between 1969 and 1971. One of the sad truths in public health is that, as public health inter ventions significantly reduce levels of a disease, it receives less funding and is assigned a lower priority because it is no longer viewed as an im minent threat. The program, rather than the disease, is eliminated! Consequently, diseases that once were suppressed later return in epi-demic proportions. This is exactly why the Childhood Immunization Initiative was created: to build a comprehensive vaccination system that is secure and sustainable-not only for today's children, but for tomor row's as well.
Childhood immunization rates are at all-time high levels. We are within striking distance of having a truly effective childhood im m uni zation system in the U nited States, and we m ust not retreat or scale back our efforts at this critical juncture. As a nation we m ust stick to our resolve never again to allow epidemics to be the primary motivation for our immunization efforts.
Although the nation would benefit unquestionably from intensified efforts to immunize more adults, taking resources from children's pro grams to accomplish this is not the answer. A dult immunization must be more fully addressed if we are to save the $12 billion spent each year on diseases that adult vaccines could prevent. The National Vaccine Program Office and CDC are working w ith HCFA and other federal agencies, as well as private sector partners, to reach and surpass the Healthy People 2000 goals of 60 percent for influenza and pneumococ cal vaccination. The NVAC identified five crucial goals and m ultiple strategies to improve adult im munization, which CDC, HCFA, and its various partners, government and private, are applying to the develop ing plan of action. As part of the assessment of the NVAC report, the Department of Health and H um an Services will consider both fiscal and programmatic issues related to the enhancement of adult immunization activities.
